Agenda for a Public Meeting of the Trust Board of Directors to Be Held

Agenda for a Public Meeting of the Trust Board of Directors to be held on 27 March 2012 at 10:30 in the Conference Room, Trust Headquarters, Marlborough Street, Bristol, BS1 3NU Item Sponsor Page 1. Chairman’s Introduction and Apologies Chairman To note apologies for absence received. 2. Declarations of Interest Chairman In accordance with Trust Standing Orders, all members present are required to declare any conflicts of interest with items on the Meeting Agenda. 3. Minutes and Matters Arising from the Previous Meeting Chairman To consider the Minutes of a Public Trust Board meeting dated Tuesday 28 February 2012 for approval. 4. Chief Executive’s Report Chief To receive this report to note. Executive Quality, Performance and Compliance 5. Summary Quality and Performance Report Executive To receive the standing Summary Quality and Performance Report to Leads note. a. Overview – Director of Strategic Development b. Quality – Medical Director and Chief Nurse c. Workforce – Director of Workforce & Organisational Development d. Access – Chief Operating Officer 6. Histopathology Action Plan Update Chief To receive this report to note. Executive 7. Infection Control Annual Programme 2012/13 Chief Nurse To receive this report to note. 8. Outpatient Feedback, including Results of the 2011 Chief Nurse National Outpatient Survey To receive this report to note. 9. Patient Experience and Involvement Strategy Chief Nurse To receive this report and consider the recommendations for approval. Finance and Governance 10. Committee Chairs’ Reports Committee To receive reports on the activities of Board Committees by their Chairs respective Chairs and consider any recommendations to note. a. Finance Committee dated 22 March 2012, including the Report of the Finance Director Page 2 of 2 of an Agenda for a Public Meeting of the Trust Board of Directors to be held on 27 March 2012 at 10:30 in the Conference Room, Trust Headquarters, Marlborough Street, Bristol, BS1 3NU Item Sponsor Page b. Quality and Outcomes Committee dated 26 March 2012. c. Audit Committee dated 26 March 2012. 11. Resources Book including Capital Programme Director of To receive this report and consider the recommendations for approval. Finance 12. Summary Monitor Quality Governance Framework Self- Chairman Assessment Report To receive this report to note. Monitor Reports 13. Report Results of Quarter 3 Compliance Framework Chief Monitoring Exercise Executive To receive this report to note. Risk 14. Review of Board Risk Management Strategy Chief To receive this report and consider the recommendation to ratify the Executive decision of the Risk Management Group to approve the strategy. Strategy and Business Planning 15. Policy Review – Capital Investment Policy Director of To receive this report and consider the recommendations for approval. Strategic Development Information and Other 16. Any Other Business Chairman To consider any other relevant matters not on the Agenda. 17. Date of Next Meeting Chairman Public Meeting of the Trust Board of Directors, Monday 30 April 2012 from 10:30 – 13:30 in the Conference Room, Trust Headquarters, Marlborough Street, Bristol, BS1 3NU. Minutes of a Public Meeting of the Trust Board of Directors held on 28 February 2012 at 10:30 in the Conference Room, Trust Headquarters, Marlborough Street, Bristol, BS1 3NU Board Members Present John Savage – Chairman Robert Woolley – Chief Executive Emma Woollett – Vice Chair Alison Moon – Chief Nurse Iain Fairbairn – Senior Independent Deborah Lee – Director of Strategic Director Development John Moore – Non-executive Director James Rimmer – Chief Operating Officer Kelvin Blake – Non-executive Director Paul Mapson – Director of Finance Lisa Gardner – Non-executive Director Sean O‟Kelly – Medical Director Paul May – Non-executive Director Steve Aumayer – Director of Workforce Selby Knox – Non-executive Director and Organisational Development Present or In Attendance Jackie Cornish – Head of Division – Anne Ford – Public Governor Division of Women‟s and Children‟s Pauline Beddoes – Public Governor Services Sue Silvey – Public Governor Mark Callaway – Head of Division – Division of Medicine Ken Booth – Public Governor Joan Bayliss – Partnership Governor Helen Morgan – Deputy Chief Nurse (shadowing Alison Moon) Clive Hamilton – Public Governor Charlie Helps – Trust Secretary Anton Horne – Head of Teaching & Learning Victoria Church – Management Assistant to the Trust Secretary Christine Perry – Director of Infection Prevention & Control Sarah Pinch – Head of Communications Jeanette Jones – Partnership Governor Vicki Mathias – Bristol Evening Post Fiona Reid – Head of External Relations Matthew Silver-Vallance – Covidien plc Item Action 1. Chairman’s Introduction and Apologies There were no apologies to note. The Chairman and Board congratulated Helen Morgan on her appointment as Deputy Chief Nurse. 2. Declarations of Interest In accordance with Trust Standing Orders, all members present are required to declare any conflicts of interest with items on the Board Meeting Agenda. No declarations of interest were made. 3. Minutes and Matters Arising from Previous Meetings The Board considered the Minutes of the Public meeting of the Trust Board of Directors dated 26 January 2012 and approved them as an accurate record. All items on the Board Schedule of Matters Arising were noted as complete as reflected in the Schedule. 1 Page 2 of 14 of Minutes of a Public meeting of the Trust Board of Directors held on 28 February 2012 at 10:30, in the Conference Room, Trust Headquarters, Marlborough Street, Bristol, BS1 3NU 4. Chief Executive’s Report The Board received and considered a report by the Chief Executive, which included the activities of the Trust Management Executive to note. Robert Woolley took the opportunity to talk about the Trust Board‟s dedication to quality, particularly with regard to Histopathology, and highlighted the following items of relevance: University Hospitals Bristol NHS Foundation Trust commissioned an Independent Inquiry in 2009 to review allegations about its Histopathology Service and to consider whether appropriate action was taken by the Trust to address the concerns. Recently, some alarmist reports had appeared in the media repeating allegations that thousands of diagnostic errors may have been made by the Trust over a ten-year period. The allegations were based on a crude extrapolation from a review of an audit of discrepancy rates submitted to the Independent Inquiry, evaluated by them and made public as part of their report. The Independent Inquiry, conducted by a panel of experts and chaired by Jane Mishcon, a leading barrister, published its report and recommendations on 08 December 2010. Patients may be reassured that the author of the review, Professor Peter Furness, President of the Royal College of Pathologists, concluded that, although he detected issues in the working practices in the department, he did not believe the audit identified a systematic pattern of error. The Inquiry found no evidence to suggest that the Histopathology department at University Hospitals Bristol NHS Foundation Trust provided anything other than a safe service. However, it did criticise the Trust for the quality of its response to concerns about clinical services. The recommendations from the Independent Inquiry were under implementation through an integrated action plan, jointly owned by University Hospitals Bristol NHS Foundation Trust and North Bristol NHS Trust, which was reported publicly at the Trust Board, Membership Council and to the Bristol Health Scrutiny Commission. The Trust had undergone unprecedented scrutiny of the quality of its Histopathology services over the last two years but had been found to be meeting essential quality and safety standards. Nonetheless, the Trust remained committed to addressing the recommendations from the Independent Inquiry and would continue to publish its progress. Robert Woolley issued a public apology on behalf of the Trust Board for the fact that a small number of patients had been harmed as a result of diagnostic mistakes and that concerns about Trust services were not promptly and thoroughly investigated at the time that they arose. The Care Quality Commission (CQC) undertook its own review of histopathology services at University Hospitals Bristol NHS Foundation Trust in 2011. They found that the Trust was meeting all six of the essential standards of quality and safety which it reviewed. The review suggested that the Trust made improvements in three areas in order to maintain compliance, 2 Page 3 of 14 of Minutes of a Public meeting of the Trust Board of Directors held on 28 February 2012 at 10:30, in the Conference Room, Trust Headquarters, Marlborough Street, Bristol, BS1 3NU and the Trust had set-out the actions being taken in those areas. The Trust had invited the Independent Inquiry panel to return to Bristol shortly, to ascertain what progress had been made against their recommendations for improvement. The Trust would publish the outcomes from this review. Iain Fairbairn confirmed that in the light of the letter of allegations with regard to the Code of Conduct for NHS managers, he had been asked to conduct an inquiry in his capacity as Senior Independent Director into whether there was a prima facie case to answer. Having assessed the allegations and responses of the Chair and Chief Executive, he confirmed that there was no case to answer. Iain Fairbairn planned to contact Mrs D Havercroft to

Load more